Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Don't get hopes up too soon for swift vaccine roll out, says UK PM

Wed, 02nd Dec 2020 12:10

LONDON, Dec 2 (Reuters) - British Prime Minister Boris
Johnson cautioned people in Britain on Wednesday not to get
their hopes up too soon about the swift roll out of the
Pfizer-BioNTech vaccine, saying there were logistical challenges
to overcome.

"I think at this stage it is very, very important that
people do not get their hopes up too soon about the speed with
which we will be able to roll out this vaccine," Johnson told
parliament.

"We are expecting several million doses of the
Pfizer-BioNTech vaccine before the end of the year. We will then
be rolling it out as fast as we possibly can."
(Reporting by William James, writing by Elizabeth Piper;
editing by Michael Holden)

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.